# A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma

> **NCT02915965** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 80 (estimated)

## Conditions studied

- Stage II and III Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** DCX
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT02915965
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-10
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02915965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02915965, "A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02915965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*